Exenatide improves antioxidant capacity and reduces the expression of LDL receptors and PCSK9 in human insulin-secreting 1.1E7 cell line subjected to hyperglycemia and oxidative stress
Łukasz Bułdak
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Orcid-ProfilSuche nach diesem Autor auf
, Estera Skudrzyk
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Orcid-ProfilSuche nach diesem Autor auf
, Grzegorz Machnik
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Orcid-ProfilSuche nach diesem Autor auf
, Aleksandra Bołdys
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Orcid-ProfilSuche nach diesem Autor auf
, Rafał Jakub Bułdak
Institute of Medical Sciences, University of OpoleOpole, Poland
Orcid-ProfilSuche nach diesem Autor auf
und Bogusław Okopień
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Orcid-ProfilSuche nach diesem Autor auf
20. Feb. 2022
Über diesen Artikel